<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+5 cells treated with 5-FU, SN-38 or oxaliplatin for 48 h and compared to untreated control cells. C, Analysis of caspase-3/7 activity in HCT116, HCT116+3 and HCT116+3+5 cells treated with 5-FU, SN-38 or oxaliplatin (48 h). Data are shown as mean ± standard errors from 3 independent experiments. Statistical significance was determined by a two-sided Student's t test (* P<0.05; † P<0.01).</p
Apoptotic dose responses of H23 and H522 cell lines to various genotoxic agents. Apoptosis assay to ...
<p>(A) TUNEL assay to evaluate apoptosis (green) in NRK-52E cells exposed to cisplatin or control. N...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p>A) Annexin V binding by flow cytometry of A549 cells with CLPTM1L knockdown after 48 hours treatm...
<p>A and B: the rate of ChEC proliferation was determined by counting the number of cells in triplic...
<p>(A, B) CX-1 and HCT116 cells were exposed to normothermic or hyperthermic (42°C) conditions for 1...
<p>A: Carboplatin-induced growth inhibition in PC9 and A549 cells using a sulforhodamine B assay 72 ...
<p>A, Apoptotic effect of anticancer drug cisplatin (5–20 μM) in response to antioxidant EGCG (50 μM...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
<p>A, D, The effect of suppression of <i>MSH3</i>, using an inducible shRNA system (doxycycline 1 µg...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p><b>Copyright information:</b></p><p>Taken from "Multi-level gene expression profiles affected by ...
<p>A) Knockdown of CLPTM1L expression in A549 cells via stable shRNA. Confirmation of knockdown by w...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
Apoptotic dose responses of H23 and H522 cell lines to various genotoxic agents. Apoptosis assay to ...
<p>(A) TUNEL assay to evaluate apoptosis (green) in NRK-52E cells exposed to cisplatin or control. N...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p>A) Annexin V binding by flow cytometry of A549 cells with CLPTM1L knockdown after 48 hours treatm...
<p>A and B: the rate of ChEC proliferation was determined by counting the number of cells in triplic...
<p>(A, B) CX-1 and HCT116 cells were exposed to normothermic or hyperthermic (42°C) conditions for 1...
<p>A: Carboplatin-induced growth inhibition in PC9 and A549 cells using a sulforhodamine B assay 72 ...
<p>A, Apoptotic effect of anticancer drug cisplatin (5–20 μM) in response to antioxidant EGCG (50 μM...
<p>A–C, MTS assay in HCT116 (<i>MLH1−/MSH3−</i>), HCT116+3 (<i>MLH1+/MSH3−</i>), and HCT116+3+5 (<i>...
<p>A, D, The effect of suppression of <i>MSH3</i>, using an inducible shRNA system (doxycycline 1 µg...
<p>A549Pt and A549cisR cells were treated for 48 hours with 5 μM and 5 μM or 25 μM cisplatin (cisPt)...
<p><b>Copyright information:</b></p><p>Taken from "Multi-level gene expression profiles affected by ...
<p>A) Knockdown of CLPTM1L expression in A549 cells via stable shRNA. Confirmation of knockdown by w...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
Apoptotic dose responses of H23 and H522 cell lines to various genotoxic agents. Apoptosis assay to ...
<p>(A) TUNEL assay to evaluate apoptosis (green) in NRK-52E cells exposed to cisplatin or control. N...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...